To demonstrate that a treatment truly works and is safe, researchers would need randomized clinical trials, clear dosing standards, and ongoing safety monitoringthe same safeguards used before any medication is approved for medical use
The analysts remained optimistic that this class of drugs will have the ability to overcome supply issues and enjoy sustained uptake. Additionally, they said we are also optimistic that reimbursement will steadily expand for weight loss, achieving over $100 billion in global sales by 2030.
These strategies compared to currently available drug medications such as thiazolidinediones, sulphonylureas, and insulin, have the potential to treat diabetes without causing side effects of hypoglycemia and weight gain
Zakaria H, Alshehhi S, Caccelli M, Ozkan C, Kattan J, Jafaar Z, et al
Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas
The robust weight loss occurring after both RYGB and VSG increases insulin sensitivity, as predicted, and might be expected to increase hypoglycaemia